SINGAPORE, 25 MARCH 2021 – Taiwan’sEVA Air and Affinidi, a Singapore-based technology company, today announced that the airline will be utilizing Affinidi’s digital credential verification solution in a pilot program with Singapore Changi Airport to verify  passengers’  Polymerase  Chain  Reaction  (PCR)  test  results for EVA’s   Singapore   toTaipei   flights.   The   airline   plans   to   extend   this   service   to flights from Malaysia and Indonesia to Taipei and is evaluating the introduction of digital systems on other routes based on trial outcomes.
‍
EVA is actively pursuing the development and deployment of digital verification platforms as part of its unwavering commitment to safeguarding the health and safety of passengers and crew members. Affinidi’s open, privacy-preserving and interoperable  technology solution will enable airline ground staff to quickly and accurately determine the authenticity of PCR test results, including the name of the medical   institution,   date   of   the   test   and   whether   the   passenger   meets relevant policy requirements in their destination country.

“EVA   upholds   rigorous   standards   for   safeguarding   the   health   and   safety   of everyone traveling onboard our airline. We are pleased to be partnering Affinidi and Singapore Changi Airport on this digital verification platform trial which will offer greater peace of mind for our passengers, while ensuring the privacy of their   health   credentials,”   said   David   Chen   (Executive   Vice   President).   “EVA   is honored to be the only airline in Taiwan to be recognized as the “World’s TopTwenty   COVID-19   Compliant  Airlines”,   and   this  pilot   program   underscores   our continual efforts in enhancing measures to manage this pandemic.

”By using Affinidi’s digital verification solution, EVA expects  to  eliminate human errors stemming from individual interpretation of test results. This will not only improve   the   passenger experience   at   the   airport,   but   also   boost operational efficiency.   Affinidi’s   solution   provides   trusted   assurance   on   the   verification process   and   is   able   to   read   and   authenticate  health   credentials   of   varying standards and formats from over 14 global providers.  

Glenn   Core,   CEO   of   Affinidi,   said:   “Affinidi   is   committed   to   working   with   the aviation industry in building an ecosystem solution to address the increasingly complex environment for international travel as countries look to re-open their borders.   We   look   forward   to   partnering   EVA   Air   on   this   trial   and   to   bringing greater convenience and confidence to travelers as we work towards our shared goal of making international travel safer for everyone.”

EVA   has   been   working   with   airline   and   aviation   industry   organizations   on establishing   a   reliable   digital   verification   solution   and   promoting   cross-border application   standardization   that   will   enable   international   systems   to   connect more   seamlessly   and   support   safe   air   travel.   Currently,   Singapore   requires travelers to present QR codes for PCR test results from medical institutions, while Taiwan   requires   passengers   to   present   a   paper   copy   of   their   PCR   test   result when they check in for the flight.

International travel is likely to resume as COVID-19 vaccines are rolled out across the globe. Standardized digital health credentials verification systems will make it easier for travelers, airline ground staff and immigration officers to verify test results and vaccination records.
‍

‍
For media enquiries, contact: 

Rachael Renovah

Affinidi

rachael.r@affinidi.com

‍